Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Goods |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): |
Awarded to (33 suppliers)
NHS South of England Branded Medicines - Tranche A - September 2023 Offer reference number: CM/PHR/22/5676 CM/PHR/22/5676/01 - NHS Framework for South of England Branded Medicines - Tranche A. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5676/02 - NHS Framework for South of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/22/5676/03 - NHS Framework Agreement for the supply of Risankizumab for the Midlands & East and North of England. Period of framework: 1 September 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
11 April 2023
Closed
Estimated Value
£249,832,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| £249,832,000 |
| Release Date: | 14 August 2023 |
| Application Deadline: | 11 April 2023 |
| Contract Start Date: | 31 August 2023 |
| Contract End Date: | 31 August 2025 |
| Contract Duration: | 2.0 years |
| Procurement ID (OCID): | ocds-b5fd17-47d90e8b-f08c-43df-8fe9-14b131b9338b |
| Notice Reference: | 7c3db894-9ea9-4129-96a0-04e021bbaf54-671788 |
View Original Notice
Access the full notice on the official portal
| Award value: | £249,832,000 |
| Award decision date: | 17 July 2023 |
| Award status: | Active |